Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Newsdesk

402 Posts

OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen Agreement With Top Medical Device Leader post image
digital-health ai health-tech

OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen Agreement With Top Medical Device Leader

Featured post
by Newsdesk
Therapists Leverage AI For Mental Health By Delving Into Virtual Digital Twins Of Their Clients And Patients Minds post image
digital-health ai health-tech

Therapists Leverage AI For Mental Health By Delving Into Virtual Digital Twins Of Their Clients And Patients Minds

by Newsdesk
Google and NASA are building an AI tool to treat health problems while astronauts are in space post image
digital-health ai health-tech

Google and NASA are building an AI tool to treat health problems while astronauts are in space

by Newsdesk
WHO launches Health Inequality Monitoring Network to catalyse progress towards health equity post image
digital-health ai health-tech

WHO launches Health Inequality Monitoring Network to catalyse progress towards health equity

Featured post
by Newsdesk
ChatGPT-5 launched: A modular, multi-modal leap-will OpenAI’s most powerful AI transform coding, health, and education forever now? post image
digital-health ai health-tech

ChatGPT-5 launched: A modular, multi-modal leap-will OpenAI’s most powerful AI transform coding, health, and education forever now?

Featured post
by Newsdesk
FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug post image
regulatory fda clinical-trials

FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug

by Newsdesk
OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen Agreement With Top Medical Device Leader post image
digital-health ai health-tech

OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen Agreement With Top Medical Device Leader

by Newsdesk
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer post image
regulatory fda clinical-trials

Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer

by Newsdesk
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts post image
pharma-industry business earnings

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

by Newsdesk
Prospective Ozempic-style drug could help Fido shed pounds post image
pharma-industry business earnings

Prospective Ozempic-style drug could help Fido shed pounds

by Newsdesk
Anlon Healthcare IPO Is Here: Is This Your Ticket To Big Returns? post image
pharma-industry business earnings

Anlon Healthcare IPO Is Here: Is This Your Ticket To Big Returns?

by Newsdesk
SUN: Catalent to lay off 350 employees at Baltimore-area facilities post image
pharma-industry business earnings

SUN: Catalent to lay off 350 employees at Baltimore-area facilities

by Newsdesk